[HTML][HTML] Melatonin regulates Aβ production/clearance balance and Aβ neurotoxicity: A potential therapeutic molecule for Alzheimer's disease

Y Li, J Zhang, J Wan, A Liu, J Sun - Biomedicine & Pharmacotherapy, 2020 - Elsevier
Alzheimer's disease (AD) is an age-related neurodegenerative disease with multiple
predisposing factors and complicated pathogenesis. Aβ peptide is one of the most important …

[HTML][HTML] Mechanisms of insulin resistance at the crossroad of obesity with associated metabolic abnormalities and cognitive dysfunction

TM Barber, I Kyrou, HS Randeva… - International journal of …, 2021 - mdpi.com
Obesity mediates most of its direct medical sequelae through the development of insulin
resistance (IR). The cellular effects of insulin occur through two main postreceptor pathways …

[HTML][HTML] Metabolic syndrome as a risk factor for Alzheimer's disease: a focus on insulin resistance

A Ezkurdia, MJ Ramírez, M Solas - International Journal of Molecular …, 2023 - mdpi.com
Alzheimer's disease (AD) is the main type of dementia and is a disease with a profound
socioeconomic burden due to the lack of effective treatment. In addition to genetics and …

[HTML][HTML] Diabetes mellitus and cognitive impairments

E Saedi, MR Gheini, F Faiz, MA Arami - World journal of diabetes, 2016 - ncbi.nlm.nih.gov
There is strong evidence that diabetes mellitus increases the risk of cognitive impairment
and dementia. Insulin signaling dysregulation and small vessel disease in the base of …

[HTML][HTML] How does brain insulin resistance develop in Alzheimer's disease?

FG De Felice, MV Lourenco, ST Ferreira - Alzheimer's & Dementia, 2014 - Elsevier
Compelling preclinical and clinical evidence supports a pathophysiological connection
between Alzheimer's disease (AD) and diabetes. Altered metabolism, inflammation, and …

[HTML][HTML] Aberrant insulin signaling in Alzheimer's disease: current knowledge

G Bedse, F Di Domenico, G Serviddio… - Frontiers in …, 2015 - frontiersin.org
Alzheimer's disease (AD) is the most common form of dementia affecting elderly people. AD
is a multifaceted pathology characterized by accumulation of extracellular neuritic plaques …

The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease

ST Ferreira, WL Klein - Neurobiology of learning and memory, 2011 - Elsevier
Alzheimer's disease (AD) is the 3rd most costly disease and the leading cause of dementia.
It can linger for many years, but ultimately is fatal, the 6th leading cause of death …

Alzheimer's disease and metabolic syndrome: A link from oxidative stress and inflammation to neurodegeneration

E Rojas‐Gutierrez, G Muñoz‐Arenas, S Treviño… - Synapse, 2017 - Wiley Online Library
Alzheimer's disease (AD) is the most common cause of dementia and one of the most
important causes of morbidity and mortality among the aging population. AD diagnosis is …

Alzheimer's disease: pathological mechanisms and the beneficial role of melatonin

SA Rosales‐Corral, D Acuña‐Castroviejo… - Journal of pineal …, 2012 - Wiley Online Library
Alzheimer's disease (AD) is a highly complex neurodegenerative disorder of the aged that
has multiple factors which contribute to its etiology in terms of initiation and progression. This …

Melatonin in Alzheimer's disease: a latent endogenous regulator of neurogenesis to mitigate Alzheimer's neuropathology

MF Hossain, MS Uddin, GMS Uddin… - Molecular …, 2019 - Springer
Melatonin, a pineal gland synthesized neurohormone is known as a multifunctioning
pleiotropic agent which has a wide range of neuroprotective role in manifold age-related …